BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Ultimate Trader

1 year 30%, 2 years 40% and *3 years 40%

*Across 3 years $3395.52 only $1697.76

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,048.09
      0.82%
      US Tech 100
      20,596.64
      1.02%
      Dow Jones
      44,804.01
      -0.24%
      Brent Oil
      71.625
      -0.62%
      Bitcoin
      95,659.65
      -1.65%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Exelixis Inc (EXEL)

      7. Exelixis Inc (EXEL) Financials

      Exelixis Inc

      Exelixis Inc (EXEL)

      NASDAQ
      35.61
      -0.85
      ( -2.33% )
      Updated: 13:34:56
      Delayed by 15 minutes

      Exelixis Inc Financial Summary

      The current EXEL market cap is 10.17B. The company's latest EPS is USD 0.7275 and P/E is 48.92.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 471.92M479.65M425.23M637.18M539.54M
      Operating Income -17.58M81.79M29.46M275.87M187.75M
      Net Income 1.04M85.52M37.32M226.12M117.97M
      Year End December 28 2023 20202021202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 967.78M987.54M1.43B1.61B1.83B
      Operating Income 369.47M110.06M286.67M201.48M170.89M
      Net Income 321.01M111.78M231.06M182.28M207.77M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.98B2.94B2.8B2.77B2.96B
      Total Liabilities 629.29M678.45M675.74M653.39M684.86M
      Total Equity 2.35B2.26B2.13B2.12B2.28B
      Year End December 28 2023 20202021202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.89B2.14B2.62B3.07B2.94B
      Total Liabilities 199.7M258.22M405.62M583.06M678.45M
      Total Equity 1.69B1.88B2.21B2.49B2.26B

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 322.75M333.32M68.82M188.37M459.71M
      Investing -88.69M-26.96M111.79M193.57M-23.58M
      Financing -339.88M-546.05M-184.05M-446.47M-440.77M
      Year End December 28 2023 20202021202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 526.96M208.98M400.8M362.61M333.32M
      Investing -587.25M-131.22M-42.88M-524.41M-26.96M
      Financing 12.55M-25.13M-14.8M586k-546.05M

      Stats and Ratios

      Market Cap 10.17B
      Price to Earnings Ratio 48.92
      Price to Sales Ratio 5.55
      Price to Cash Ratio 38.65
      Price to Book Ratio 4.49
      Dividend Yield -

      Share Statistics

      Shares Outstanding 285.58M
      Average Volume (1 week) 1.75M
      Average Volume (1 Month) 2.05M
      52 Week Change 63.05%
      52 Week High 36.97
      52 Week Low 19.20
      Spread (Intraday) 0.01 (0.03%)

      Company Info

      Company Name Exelixis Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.exelixis.com
      Industry biological pds,ex diagnstics (2836)